Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cohen Independent Research Group is an independent investment research firm that specializes in the healthcare, biotechnology, and pharmaceutical sectors. The firm provides institutional investors with detailed fundamental analysis, valuation models, and strategic insights into emerging medical technologies and drug development pipelines. Led by Michael Cohen, the group focuses on identifying market inefficiencies and providing objective evaluations of clinical data and regulatory pathways. Their services are designed to help clients navigate the complexities of life science investments through rigorous, conflict-free research. The company is recognized for its focus on small-to-mid-cap biotech entities that are often under-covered by larger Wall Street firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cohen Independent Research Group.